Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4434881
Max Phase: Preclinical
Molecular Formula: C25H20FN3O3
Molecular Weight: 429.45
Molecule Type: Unknown
Associated Items:
ID: ALA4434881
Max Phase: Preclinical
Molecular Formula: C25H20FN3O3
Molecular Weight: 429.45
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccncc2)c1C
Standard InChI: InChI=1S/C25H20FN3O3/c1-16-17(2)23(32-20-11-13-27-14-12-20)10-9-22(16)28-24(30)21-4-3-15-29(25(21)31)19-7-5-18(26)6-8-19/h3-15H,1-2H3,(H,28,30)
Standard InChI Key: JSQPARPVIOODMR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 429.45 | Molecular Weight (Monoisotopic): 429.1489 | AlogP: 5.03 | #Rotatable Bonds: 5 |
Polar Surface Area: 73.22 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.87 | CX Basic pKa: 5.95 | CX LogP: 4.37 | CX LogD: 4.36 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.48 | Np Likeness Score: -1.58 |
1. Hart AC, Abell L, Guo J, Mertzman ME, Padmanabha R, Macor JE, Chaudhry C, Lu H, O'Malley K, Shaw PJ, Weigelt C, Pokross M, Kish K, Kim KS, Cornelius L, Douglas AE, Calambur D, Zhang P, Carpenter B, Pitts WJ.. (2020) Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage., 11 (3): [PMID:32184955] [10.1021/acsmedchemlett.9b00065] |
Source(1):